Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2021 / Cilt: 55 - Sayı: 3

Frequency and Prognosis of Hydrops Fetalis: A 10-Year Single-Center Experience

Pages
366–373
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, it was determined that HF mostly developed for non-immune reasons, prenatal diagnosis and follow-up were insufficient and the interventions performed in the delivery room were an important factor in predicting mortality in the follow-up of neonates with HF

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The study aims to evaluate the etiological distribution and prognosis of newborn infants with hydrops fetalis (HF).
📊
Key Findings & Data:Methods: All infants born in our hospital within the past 10 years and hospitalized with the diagnosis of HF were included in this retrospective descriptive study.
💡
Conclusion & Impact:In this study, it was determined that HF mostly developed for non-immune reasons, prenatal diagnosis and follow-up were insufficient and the interventions performed in the delivery room were an important factor in predicting mortality in the follow-up of neonates with HF
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: The study aims to evaluate the etiological distribution and prognosis of newborn infants with hydrops fetalis (HF). Methods: All infants born in our hospital within the past 10 years and hospitalized with the diagnosis of HF were included in this retrospective descriptive study. Demographic characteristics, etiological distributions, treatment interventions, and prognosis information of the infants were recorded retrospectively. Infants with incomplete data were excluded from the study. Results: The mean gestational age of infants with HF was 33.6±3.1 weeks, and the mean birth weight was 2444±792 grams. Of the HF cases, 90.5% were born by cesarean section and the prenatal diagnosis rate was 42.9%. About 57.1% of the infants were intubated during resuscitation at birth in the delivery room. In the NICU, 81% of the cases were intubated and 71.4% received surfactant treatment. The most common HF findings were ascites (81%) and subcutaneous edema (81%). The most common interventional procedures were paracentesis (81%) and thoracentesis (52.4%). Exchange transfusion was performed in 2 cases (9.5%) due to immune HF. The mortality rate in the study group was 52.4%. Considering the etiological distribution of HF cases in the study group, three cases were diagnosed with immune HF (14.3%) and 18 cases with non-immune hydrops fetalis (NIHF) (85.7%). The underlying cause in immune HF cases was rhesus incompatibility. In cases with NIHF, idiopathic (23.8%) and cardiovascular diseases were the most common etiologies. A significant relationship was found between delivery room management and mortality. While the need for intubation in delivery room was significantly higher in non-survivors, the frequency of applying only positive pressure ventilation in the delivery room was significantly higher in survivors. While the rate of survival was 66.7% in immune HF cases, it was 44.4% in NIHF cases. Conclusion: The risk of perinatal mortality in infants with HF is high depending on the underlying cause. In this study, it was determined that HF mostly developed for non-immune reasons, prenatal diagnosis and follow-up were insufficient and the interventions performed in the delivery room were an important factor in predicting mortality in the follow-up of neonates with HF

🔖

Cite This Article

ÜNAL, E. T., BÜLBÜL, A., BAŞ, E. K., USLU, S. (2021). Frequency and Prognosis of Hydrops Fetalis: A 10-Year Single-Center Experience. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 55 - Sayı: 3, 366–373. https://ajindex.com/articles/363371

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Society for Maternal-Fetal Medicine (SMFM), Norton ME, Chauhan SP, Dashe JS. Society for maternal-fetal medicine (SMFM) clinical guideline #7: nonimmune hydrops fetalis. Am J Obstet Gynecol 2015
  2. 127–39. [CrossRef] 2. Randenberg AL. Nonimmune hydrops fetalis part I: etiology and pathophysiology. Neonatal Netw 2010
  3. 281–95. [CrossRef] 3. Heinonen S, Ryynänen M, Kirkinen P. Etiology and outcome of second trimester non-immunologic fetal hydrops. Acta Obstet Gynecol Scand 2000
  4. 15–8. [CrossRef] 4. Takci S, Gharibzadeh M, Yurdakok M, Ozyuncu O, Korkmaz A, Akcoren Z, et al. Etiology and outcome of hydrops fetalis: report of 62 cases. Pediatr Neonatol 2014
  5. 108–13. [CrossRef] 5. Bellini C, Hennekam RC, Fulcheri E, Rutigliani M, Morcaldi G, Boccardo F, et al. Etiology of nonimmune hydrops fetalis: a systematic review. Am J Med Genet A 2009
  6. 149A:844–51. [CrossRef] 6. Bellini C, Hennekam RC. Non-immune hydrops fetalis: a short review of etiology and pathophysiology. Am J Med Genet A 2012
  7. 158A:597–605. [CrossRef] 7. Nassr AA, Ness A, Hosseinzadeh P, Salmanian B, Espinoza J, Berger V, et al. Outcome and Treatment of Antenatally Diagnosed Nonimmune Hydrops Fetalis. Fetal Diagn Ther 2018
  8. 123–8. [CrossRef] 8. Emiroğlu N, Yılmaz FH, Keçeci R, Yücel M, Gültekin ND, Altunhan H. Clinical characteristics and neonatal outcomes of liveborn newborns with hydrops fetalis treated in a tertiary level neonatal intensive care unit. Birth Defects Res 2020
  9. 515–22. [CrossRef ] 9. Karadag N, Dilli D, Karagöl B, Dursun A, Kundak A, Hakan N, et al. Hidrops fetalis: Üçüncü düzey bir yenidoğan yoğun bakım ünitesinde 6 yıllık deneyim. Yeni Tıp Dergisi 2013
  10. 181–6. 10. Fukushima K, Morokuma S, Fujita Y, Tsukimori K, Satoh S, Ochiai M, et al. Short-term and long-term outcomes of 214 cases of non-immune hydrops fetalis. Early Hum Dev 2011
  11. 571–5. [CrossRef] 11. Ota S, Sahara J, Mabuchi A, Yamamoto R, Ishii K, Mitsuda N. Perinatal and one-year outcomes of non-immune hydrops fetalis by etiology and age at diagnosis. J Obstet Gynaecol Res 2016
  12. 385–91. [CrossRef] 12. Gilby DM, Mee JB, Kamlin COF, Kornman LH, Davis PG, Manley BJ. Outcomes following antenatal identification of hydrops fetalis: a single-centre experience from 2001 to 2012. Arch Dis Child Fetal Neonatal Ed 2019
  13. F253–8. [CrossRef] 13. Steurer MA, Peyvandi S, Baer RJ, MacKenzie T, Li BC, Norton ME, et al. Epidemiology of Live Born Infants with Nonimmune Hydrops Fetalis-Insights from a Population-Based Dataset